HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jennifer Vermette Selected Research

2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- one

12/2017A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer.
7/2016A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jennifer Vermette Research Topics

Disease

3Neoplasms (Cancer)
12/2017 - 04/2009
3Diarrhea
07/2016 - 04/2009
3Breast Neoplasms (Breast Cancer)
12/2013 - 04/2009
2Endometrial Neoplasms (Endometrial Cancer)
12/2017 - 07/2016
2Fatigue
07/2016 - 04/2009
2Nausea
07/2016 - 04/2009
2Vomiting
07/2016 - 04/2009
1Ovarian Neoplasms (Ovarian Cancer)
12/2017
1Colorectal Neoplasms (Colorectal Cancer)
12/2017
1Pneumonia (Pneumonitis)
07/2016
1Dysgeusia (Parageusia)
07/2016
1Inflammation (Inflammations)
07/2016
1Cardiotoxicity
03/2010
1Anorexia
04/2009

Drug/Important Bio-Agent (IBA)

3Trastuzumab (Herceptin)FDA Link
12/2013 - 04/2009
3neratinibIBA
12/2013 - 04/2009
2gedatolisibIBA
12/2017 - 07/2016
22- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA
12/2017 - 07/2016
2ErbB Receptors (EGF Receptor)IBA
03/2010 - 04/2009
2Tyrosine Kinase InhibitorsIBA
03/2010 - 04/2009
1Irinotecan (Camptosar)FDA LinkGeneric
12/2017
1mirdametinibIBA
12/2017
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2017
1MTOR InhibitorsIBA
12/2017
1StathminIBA
07/2016
1PlatinumIBA
07/2016
1Lapatinib (GW572016)FDA Link
12/2013
1Capecitabine (Xeloda)FDA Link
12/2013
1Epidermal Growth Factor (EGF)IBA
12/2013
1AntidiarrhealsIBA
03/2010
1AnthracyclinesIBA
04/2009
1Taxoids (Taxanes)IBA
04/2009

Therapy/Procedure

1Intravenous Infusions
07/2016
1Drug Therapy (Chemotherapy)
07/2016
1Therapeutics
12/2013
1Drug Tapering
03/2010